
This drug should not be administered to domestic food-producing animals.
Not for use in horses intended for food.
Avoid accidental administration to humans. Should such exposure occur, notify a physician immediately. Artificial respiration may be indicated.
In Cervidae, occasional capture-associated deaths occur. Clinical trials reveal a mortality rate of approximately 3.5% attendant with the administration of xylazine.
There is currently no manufacturer warning information available for this drug.
Xylazine should be used in horses and Cervidae (Fallow Deer, Mule Deer, Sika Deer, White-Tailed Deer and Elk) when it is desirable to produce a state of sedation accompanied by a shorter period of analgesia.
Horses: Xylazine has been used successfully as follows:
Cervidae: Xylazine may be used for the following:
AnaSed® LA is supplied in 50 mL multipledose vials as a sterile solution.
EACH ML CONTAINS: Xylazine hydrochloride equivalent to 100 mg of base activity, methylparaben 0.9 mg, propylparaben 0.1 mg, sodium citrate dihydrate 5.0 mg and water for injection. pH adjusted with citric acid and sodium citrate.
Protect from heat. Do not store over 30° C (86° F).